Anesthesia for Patients Undergoing Orthopedic Oncologic Surgeries Michael R

Total Page:16

File Type:pdf, Size:1020Kb

Anesthesia for Patients Undergoing Orthopedic Oncologic Surgeries Michael R Journal of Clinical Anesthesia (2010) 22, 565–572 Review article Anesthesia for patients undergoing orthopedic oncologic surgeries Michael R. Anderson MD (Fellow)a, Christina L. Jeng MD (Assistant Professor)a,b, James C. Wittig MD (Associate Professor)b, Meg A. Rosenblatt MD (Professor)a,b,⁎ aDepartment of Anesthesiology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA bDepartment of Orthopaedics, Mount Sinai School of Medicine, New York, NY 10029-6574, USA Received 12 November 2009; revised 23 February 2010; accepted 23 February 2010 Keywords: Abstract When planning an anesthetic for patients undergoing orthopedic oncologic surgeries, Anesthesia; numerous factors must be considered. Preoperative evaluation may elucidate significant co-morbidities Orthopedic; or side effects secondary to chemotherapy or radiation, which can affect anesthetic choices. Procedures Bone tumors; vary in length and complexity and pose challenges in both positioning and in planning to minimize Chrondrosarcoma; blood loss. Many anesthetic techniques are available to provide both intraoperative anesthesia and Ewing's sarcoma; postoperative analgesia, while the type of thromboprophylaxis and analgesic adjuvants that will be Orthopedic oncologic administered needs to be defined. This review focuses on approaches to use when caring for patients surgery; undergoing orthopedic oncologic procedures. Osteosarcoma; © 2010 Elsevier Inc. All rights reserved. Patient positioning; Thromboprophylaxis 1. Introduction 2. Primary bone sarcomas The National Cancer Institute reports that there were There are three common primary bone sarcomas. approximately 2,600 new cases of primary bone malig- Osteosarcoma, the most common bone sarcoma, has an nancies in 2009 as well as numerous other metastatic incidence of 4.6 per million people. The majority of these bone tumors. Despite the relatively common frequency, tumors occur in patients between 10 and 19 years of age, there is a paucity of information about the delivery of but there is also an association with Paget's disease in anesthesia for orthopedic oncologic surgeries. There are adults who are older than 40. Fifty percent of osteosarco- preoperative, intraoperative, and postoperative concerns mas arise around the knee, and they are also often seen in specific to these patients and procedures which, therefore, the upper arm. Ewing's sarcoma is primarily a disease of merit discussion. adolescence, with a peak incidence of about three cases per million in the 15 to 19-year age group. Although rare, Ewing's sarcoma is the second most common bone sarcoma affecting children and adolescents. It is more prevalent in ⁎ Corresponding author. Tel.: +1 212 241 7467; fax: +1 212 876 3906. men; it affects Caucasians primarily; and it frequently E-mail address: [email protected] (M.A. Rosenblatt). occurs in the spine, pelvis, arm, or leg. Chondrosarcoma is 0952-8180/$ – see front matter © 2010 Elsevier Inc. All rights reserved. doi:10.1016/j.jclinane.2010.02.011 566 M.R. Anderson et al. the most common bone sarcoma in adults. It mainly affects Table 1 Chemotherapeutic agents and their common side patients greater than age 50. The incidence is 8 per million effects people. Chondrosarcomas arise most commonly from the Chemotherapeutic Agent Side effects pelvis, upper femur, and shoulder girdle [1]. The prognosis of chondrosarcoma varies depending on the primary DNA-altering drugs Cyclophosphamide Hemorrhagic cystitis location and extent of spread. Myelosuppression Cisplatin Myelosuppression Nephrotoxicity 3. Metastatic tumors Mechlorethamine Myelosuppression Dermatitis Carboplatin Myelosuppression Metastatic bone tumors occur more frequently than Peripheral neuropathy primary tumors. The exact incidence of metastatic bone Immune hypersensitivity reaction disease is difficult to quantify because of the large number of Anti-tumor antibiotics primary cancers that may spread to the skeleton. Breast and Doxorubicin Myelosuppression prostate cancers tend to be the most common causes of bony Cardiomyopathy metastases [2], with up to 70% of patients with advanced Arrhythmias disease developing bone metastases. Lung, kidney, thyroid, Bleomycin Pulmonary fibrosis colon, stomach, bladder, uterine, and rectal malignancies Idarubicin Myelosuppression also metastasize to the bone in 15% to 30% of cases [2].Itis Hepatotoxicity Antimetabolites estimated that 350,000 people a year die with concomitant Gemcitabine Myelosuppression bone metastases [2]. Methotrexate Hepatotoxicity Ulcerative stomatitis Myelosuppression 4. Preoperative considerations Cytarabine Myelosuppression Hyperuricemia Etopiside Myelosuppression Patients who undergo surgery for bony tumors often Hypotension have received considerable medical treatment prior to Antimitotic drugs surgery. Possible side effects of preoperative chemotherapy Vincristine Motor weakness are shown in Table 1. Patients who have undergone Peripheral neuropathy chemotherapy or radiation therapy may have significant Hyponatremia anemia and thrombocytopenia, and thus might benefit from Vinblastine Myelosuppression preoperative exogenous erythropoietin administration and Ulcer/blister formation packed red blood cell (PRBC) or platelet transfusions. Paclitaxel Myelosuppression Paresthesia Obtaining adequate intravenous (IV) access and invasive Docetaxel Myelosuppression monitors in preparation for fluid resuscitation and possible Monoclonal antibody transfusions, may prove challenging secondary to ongoing Cetuximab Skin changes oncologic treatments. If the possibility of large blood loss Electrolyte disturbances from a highly vascular tumor is expected, preoperative Other embolization of the tumor may be beneficial and should be Gefitinib Diarrhea considered [3]. Interstitial lung disease Communication with the surgeon is mandatory prior to Imatinib Edema orthopedic oncologic surgeries. It allows the anesthesiolo- All information adapted from Micromedex/PDR. gist to appreciate the subtleties of each specific procedure (http://www.thomsonhc.com/hcs/librarian, Sept 2010). and to permit the planning for appropriate monitoring DNA = deoxyribonucleic acid. and access. than 12 hours and occasionally require staging. Many 5. Intraoperative considerations procedures often require major neurovascular dissection, removal of significant bone and/or muscle, replacement of There is huge variability of complexity and duration of large segments of bone and adjacent joints that may also orthopedic oncologic surgeries (Table 2). In fact, there are necessitate significant cement boluses for fixation, and approximately 50 different types of procedures performed by rotational and free flaps. A clear understanding of what the orthopedic oncology surgeons. While a bone biopsy may surgery entails allows for proper positioning, airway take less than an hour, a hemipelvectomy may extend more management, and postoperative planning. Anesthesia in orthopedic oncologic surgeries 567 Table 2 Commonly performed orthopedic oncologic surgeries For the prone position, the patient's neck is maintained Above-the-knee and below-the-knee amputation in a neutral position during and after positioning to decrease Above elbow amputation the risk of spinal cord ischemia and stretching of the Currettage of benign and benign aggressive bone tumors and brachial plexus. The eyes should be checked routinely to bone grafting ensure that there is no pressure applied directly to the globe. Distal femur resection with bone and soft-tissue reconstruction Prone positioning has been implicated in the occurrence of Excision of soft-tissue masses postoperative visual loss, especially when accompanied by Fixation of pathological fractures and impending fractures large blood loss or prolonged surgical duration. Depending Forequarter amputation on the area of surgery, the arms are placed either up and Hemipelvectomy adjacent to the head with the elbows flexed or adducted Hip disarticulation alongside the patient. In each case, the arms should be Long-stem arthroplasties and cemented nails padded to prevent compression injuries. Excessive pressure Proximal femur resection with bone and soft-tissue reconstruction on the breasts also must be avoided. The abdomen should Proximal humerus resection with bone and soft-tissue not be compressed because excessive pressure may reconstruction compromise ventilation and decrease venous return from Proximal tibia resection with bone and soft-tissue reconstruction the lower extremities. Total scapula resection and reconstruction, including multiple Poor patient positioning may result in devastating muscle flaps outcomes. The anesthesiologist and surgeon should be Radical lymph node dissections aware of the common pitfalls and attempt to avoid Radical pelvic resections with limb preservation preventable injuries. Radical soft-tissue sarcoma resection with major neurovascular dissections and muscle flaps Radical synovectomy of knee and other joints 5.2. Blood loss Sacrectomy Shoulder disarticulation Tumors are relatively vascular structures and thus are prone to bleeding throughout the intraoperative period. Renal cell and thyroid metastases cause significant neovasculariza- tion to the area, often hemorrhaging dramatically during surgery, much more so than other types of bony metastases. 5.1. Positioning Preoperative embolization of these types of metastases should be considered to minimize bleeding during the Tumors may arise in any portion of the musculoskeletal surgical procedure. The location of the metastasis
Recommended publications
  • Clinical Practice Guideline for Limb Salvage Or Early Amputation
    Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline Adopted by: The American Academy of Orthopaedic Surgeons Board of Directors December 6, 2019 Endorsed by: Please cite this guideline as: American Academy of Orthopaedic Surgeons. Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline. https://www.aaos.org/globalassets/quality-and-practice-resources/dod/ lsa-cpg-final-draft-12-10-19.pdf Published December 6, 2019 View background material via the LSA CPG eAppendix Disclaimer This clinical practice guideline was developed by a physician volunteer clinical practice guideline development group based on a formal systematic review of the available scientific and clinical information and accepted approaches to treatment and/or diagnosis. This clinical practice guideline is not intended to be a fixed protocol, as some patients may require more or less treatment or different means of diagnosis. Clinical patients may not necessarily be the same as those found in a clinical trial. Patient care and treatment should always be based on a clinician’s independent medical judgment, given the individual patient’s specific clinical circumstances. Disclosure Requirement In accordance with AAOS policy, all individuals whose names appear as authors or contributors to this clinical practice guideline filed a disclosure statement as part of the submission process. All panel members provided full disclosure of potential conflicts of interest prior to voting on the recommendations contained within this clinical practice guideline. Funding Source This clinical practice guideline was funded exclusively through a research grant provided by the United States Department of Defense with no funding from outside commercial sources to support the development of this document.
    [Show full text]
  • En Bloc Resection of Extra-Peritoneal Soft Tissue Neoplasms Incorporating a Type III Internal Hemipelvectomy: a Novel Approach Sanjay S Reddy1* and Norman D Bloom2
    Reddy and Bloom World Journal of Surgical Oncology 2012, 10:222 http://www.wjso.com/content/10/1/222 WORLD JOURNAL OF SURGICAL ONCOLOGY REVIEW Open Access En bloc resection of extra-peritoneal soft tissue neoplasms incorporating a type III internal hemipelvectomy: a novel approach Sanjay S Reddy1* and Norman D Bloom2 Abstract Background: A type III hemipelvectomy has been utilized for the resection of tumors arising from the superior or inferior pubic rami. Methods: In eight patients, we incorporated a type III internal hemipelvectomy to achieve an en bloc R0 resection for tumors extending through the obturator foramen or into the ischiorectal fossa. The pelvic ring was reconstructed utilizing marlex mesh. This allowed for pelvic stability and abdominal wall reconstruction with obliteration of the obturator space to prevent herniations. Results: All eight patients had an R0 resection with an overall survival of 88% and with average follow up of 9.5 years. Functional evaluation utilizing the Enneking classification system, which evaluates motion, pain, stability and strength of the affected extremity, revealed a 62% excellent result and a 37% good result. No significant complications were associated with the operative procedure. Marlex mesh reconstruction provided pelvic stability and eliminated all hernial defects. Conclusion: The superior and inferior pubic rami provide a barrier to a resection for tumors that arise in the extra-peritoneal pelvis extending through the obturator foramen or ischiorectal fossa. Incorporating a type III internal
    [Show full text]
  • Use of Anterolateral Thigh Flap for Reconstruction of Traumatic Bilateral Hemipelvectomy After Major Pelvic Trauma
    Al‑wageeh et al. surg case rep (2020) 6:247 https://doi.org/10.1186/s40792‑020‑01009‑2 CASE REPORT Open Access Use of anterolateral thigh fap for reconstruction of traumatic bilateral hemipelvectomy after major pelvic trauma: a case report Saleh Al‑wageeh1 , Faisal Ahmed2* , Khalil Al‑naggar3 , Mohammad Reza Askarpour4 and Ebrahim Al‑shami5 Abstract Background: Major pelvic trauma (MPT) with traumatic hemipelvectomy (THP) is rare, but it is a catastrophic health problem caused by high‑energy injury leading to separation of the lower extremity from the axial skeleton, which is associated with a high incidence of intra‑abdominal and multi‑systemic injuries. THP is generally performed as a lifesaving protocol to return the patient to an active life. Case report: A 12‑year male patient exposed to major pelvic trauma with bilateral THP survived the trauma and mul‑ tiple lifesaving operations. The anterolateral thigh fap is the method used for wound reconstruction. The follow‑up was ended with colostomy and cystostomy with wheelchair mobilization. To the best of our knowledge, there have been a few bilateral THP reports, and our case is the second one to be successfully treated with an anterolateral thigh fap. Conclusion: MPT with THP is the primary cause of death among trauma patients. Life‑threatening hemorrhage is the usual cause of death, which is a strong indication for THP to save life. Keywords: Amputation, Hemipelvectomy, Myocutaneous fap, Reconstruction, Trauma Introduction A few victims survive these injuries, and the actual Major pelvic trauma (MPT) associated with traumatic incidence is unknown, but it is usually underestimated hemipelvectomy (THP) was described frst by Turnbull in [3].
    [Show full text]
  • Electromyography and Nerve Conduction Studies in Patients With
    ogy & N ol eu ur e ro N p h f y o s l Ziegler MS, J Neurol Neurophysiol 2014, 5:3 i o a l n o r g u y o DOI: 10.4172/2155-9562.1000203 J Journal of Neurology & Neurophysiology ISSN: 2155-9562 Research Article Open Access Electromyography and Nerve Conduction Studies in Patients with Lumbar Spinal Stenosis: Is Neurophysiological Examination an Important Tool? Marcus Sofia Ziegler1, Renata Siciliani Scalco2, Erasmo de Abreu Zardo1, Jefferson Becker2 and Irenio Gomes2* 1Department of Orthopaedics & Spine Surgery, Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil 2Department of Neurology, Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil *Corresponding author: Irenio Gomes, Hospital Sao Lucas, and Avenida Ipiranga 6690 - 3 ºandar - IGG Porto Alegre - RS – Brasil, CEP 90610-000, Tel: +55 (51) 3336.8153 / 3320.3000; E-mail: [email protected] Received Date: Jan 21, 2014 Accepted Date: Apr 25, 2014 Published Date: Apr 30, 2014 Copyright: © 2014 Ziegler MS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Background: There is no single test that defines properly lumbar spinal stenosis (LSS) diagnosis, and diagnosis of the syndrome continues to rely on clinical judgment. LSS symptoms may be broad and may be seen in multiple disorders in elderly. Hypothesis: To identify the role of electromyography and nerve-conduction studies on LSS diagnosis.
    [Show full text]
  • Code Procedure Cpt Price University Physicians Group
    UNIVERSITY PHYSICIANS GROUP (UPG) PRICES OF PROVIDER SERVICES CODE PROCEDURE MOD CPT PRICE 0001A IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 1ST DOSE 0001A $40.00 0002A IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 2ND DOSE 0002A $40.00 0011A IMM ADMN SARSCOV2 100 MCG/0.5 ML 1ST DOSE 0011A $40.00 0012A IMM ADMN SARSCOV2 100 MCG/0.5 ML 2ND DOSE 0012A $40.00 0021A IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 1ST DOSE 0021A $40.00 0022A IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 2ND DOSE 0022A $40.00 0031A IMM ADMN SARSCOV2 AD26 5X10^10 VP/0.5 ML 1 DOSE 0031A $40.00 0042T CEREBRAL PERFUS ANALYSIS, CT W/CONTRAST 0042T $954.00 0054T BONE SURGERY USING COMPUTER ASSIST, FLURO GUIDED 0054T $640.00 0055T BONE SURGERY USING COMPUTER ASSIST, CT/ MRI GUIDED 0055T $1,188.00 0071T U/S LEIOMYOMATA ABLATE <200 CC 0071T $2,500.00 0075T 0075T PR TCAT PLMT XTRC VRT CRTD STENT RS&I PRQ 1ST VSL 26 26 $2,208.00 0126T CAROTID INT-MEDIA THICKNESS EVAL FOR ATHERSCLER 0126T $55.00 0159T 0159T COMPUTER AIDED BREAST MRI 26 26 $314.00 PR RECTAL TUMOR EXCISION, TRANSANAL ENDOSCOPIC 0184T MICROSURGICAL, FULL THICK 0184T $2,315.00 0191T PR ANT SEGMENT INSERTION DRAINAGE W/O RESERVOIR INT 0191T $2,396.00 01967 ANESTH, NEURAXIAL LABOR, PLAN VAG DEL 01967 $2,500.00 01996 PR DAILY MGMT,EPIDUR/SUBARACH CONT DRUG ADM 01996 $285.00 PR PERQ SAC AGMNTJ UNI W/WO BALO/MCHNL DEV 1/> 0200T NDL 0200T $5,106.00 PR PERQ SAC AGMNTJ BI W/WO BALO/MCHNL DEV 2/> 0201T NDLS 0201T $9,446.00 PR INJECT PLATELET RICH PLASMA W/IMG 0232T HARVEST/PREPARATOIN 0232T $1,509.00 0234T PR TRANSLUMINAL PERIPHERAL ATHERECTOMY, RENAL
    [Show full text]
  • Why Electromyoneurography Instead Of
    Neurological Disorders and Therapeutics Research Article ISSN: 2514-4790 Why electromyoneurography instead of electromyography and electroneurography? Electroneurography is essential for interpretation of electromyographic results! Anica Jušić* Shool of Medicine University of Zagreb, Zagreb, 10000 Zagreb, Gundulićeva 49, Croatia Abstract The author suggests revival and further development of old method who had proven to be of significant benefit in differential dignostics of nerve lesions and displayed significant research possibilities. The basic idea is the unification of electromyographic results with neural stimulation. Therefore the author suggests again, to use new name - Electromyoneurography for the old methods. Introduction electrodes as I learned at Albrecht Struppler’s laboratory. The stimulation may be done with surface electrodes also, but the reliability, George Bernard Shaw once wrote: „The single biggest problem constancy and reproducibility of the results, with such technique, in communication is the illusion that it has taken place“. I hope this decreases significantly. With needle electrodes, by simple switching introductory part will make possible, among nowadays achieved of the polarity, besides the efferent motor conduction velocity the scientific circumstances, usage and further development of methods additional afferent conduction velocity measurements can be done. If differentiated some decades ago in Centre /Institute for neuromuscular necessary, the ribbon electrodes for percutaneous evocation of sensory disease, of University Hospital Clinic Zagreb, which I have founded, potentials may be involved. 1973. The purpose of this review is to shed the light on the old methods who had proven to be of significant benefit in differential dignosis of Analyses of evoked muscle or nerve potentials clarifyes so many nerve lesions and possible basis for further scientific research.
    [Show full text]
  • Cross-Sectional Imaging in the Evaluation of Osteogenic Sarcoma: MRI and CT
    Cross-sectional Imaging in the Evaluation of Osteogenic Sarcoma: MRI and CT By Leanne L. Seeger, Jeffrey J. Eckardt, and Lawrence W. Bassett EFORE the advent of cross-sectional scan- for treatment. Magnetic resonance imaging and B ning techniques, imaging of malignant bone CT image acquisition should address specific tumors was confined to plain radiography and issues that are important to the surgeon and radionuclide bone scanning. While radiography should be tailored according to tumor location remains the primary imaging modality for differ- and proposed surgical treatment, whether it be ential diagnosis, magnetic resonance imaging amputation or resection with limb salvage proce- (MRI) and computed tomography (CT) have dure. had a profound impact on the preoperative stag- The following discussion reflects the scanning ing evaluation of bone tumors and their response principles and techniques we use for evaluating to therapy. patients with OGS both preoperatively and post- In this article we will define the role of MRI operatively. This was derived from both our own and CT in the work-up of the patient with known experience and the experience of others as re- osteogenic sarcoma (OGS), stressing imaging ported in the literature. ‘-’ Regional differences in strategies that optimize information available to the management of patients with malignant bone the clinician and assist in therapy planning. In tumors may alter this procedure. To become order to achieve these optimal factors, communi- familiar with local treatment protocols, commu- cation with the referring physician and review of nicate directly with the surgeon who will ulti- available radiographs and radionuclide bone scans mately be responsible for treatment.
    [Show full text]
  • ICD-9-CM Procedures (FY10)
    2 PREFACE This sixth edition of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is being published by the United States Government in recognition of its responsibility to promulgate this classification throughout the United States for morbidity coding. The International Classification of Diseases, 9th Revision, published by the World Health Organization (WHO) is the foundation of the ICD-9-CM and continues to be the classification employed in cause-of-death coding in the United States. The ICD-9-CM is completely comparable with the ICD-9. The WHO Collaborating Center for Classification of Diseases in North America serves as liaison between the international obligations for comparable classifications and the national health data needs of the United States. The ICD-9-CM is recommended for use in all clinical settings but is required for reporting diagnoses and diseases to all U.S. Public Health Service and the Centers for Medicare & Medicaid Services (formerly the Health Care Financing Administration) programs. Guidance in the use of this classification can be found in the section "Guidance in the Use of ICD-9-CM." ICD-9-CM extensions, interpretations, modifications, addenda, or errata other than those approved by the U.S. Public Health Service and the Centers for Medicare & Medicaid Services are not to be considered official and should not be utilized. Continuous maintenance of the ICD-9- CM is the responsibility of the Federal Government. However, because the ICD-9-CM represents the best in contemporary thinking of clinicians, nosologists, epidemiologists, and statisticians from both public and private sectors, no future modifications will be considered without extensive advice from the appropriate representatives of all major users.
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • The Hypotonic Infant: Clinical Approach
    Journal of Pediatric Neurology 5 (2007) 181–187 181 IOS Press Review Article The hypotonic infant: Clinical approach Mohammed M.S. Jan∗ Department of Pediatrics, King Abdulaziz University Hospital, and Department of Neurosciences, King Faisal Specialist Hospital & RC, Jeddah, Saudi Arabia Received 27 November 2006 Revised 25 December 2006 Accepted 31 December 2006 Abstract. Hypotonia in infants can be a confusing clinical presentation leading to inaccurate evaluation and unnecessary investigations. Hypotonia can result from a variety of central or peripheral causes. Therefore, hypotonia is a phenotype of many clinical conditions with variable prognosis. It is important to recognize that hypotonia is not equivalent to weakness. Infants with central causes, such as Down syndrome, may have severe hypotonia with normal muscle strength. Peripheral hypotonia is frequently associated with weakness, which can be predominantly distal in neuropathies or predominantly proximal in myopathies. In general, central hypotonia is much more commonly encountered; however, the prognosis is worst for hypotonia secondary to neuromuscular pathology. The distinction between central and peripheral hypotonia is therefore critical for proper evaluation and management. Stepwise and accurate assessment is very important to reach the correct diagnosis promptly. In this review, I present a concise clinical approach for evaluating the hypotonic infant. Some practical tips and skills are discussed to improve the likelihood of obtaining an accurate diagnosis. Reaching a specific diagnosis is needed for providing appropriate therapy, prognosis, and counseling. Keywords: Infant, child, hypotonia, floppy, examination, approach 1. Introduction rological disorders one of the most difficult aspects of their clinical practice [6–8]. Hypotonia in infants Neurological disorders are common in Saudi Ara- and children can be a confusing clinical presentation, bia accounting for 25–30% of all consultations to pe- which often leads to inaccurate evaluation and unnec- diatrics [1].
    [Show full text]
  • Evaluating the Patient with Suspected Radiculopathy
    EVALUATINGEVALUATING THETHE PATIENTPATIENT WITHWITH SUSPECTEDSUSPECTED RADICULOPATHYRADICULOPATHY Timothy R. Dillingham, M.D., M.S Professor and Chair, Department of Physical Medicine and Rehabilitation The Medical College of Wisconsin. RadiculopathiesRadiculopathies PathophysiologicalPathophysiological processesprocesses affectingaffecting thethe nervenerve rootsroots VeryVery commoncommon reasonreason forfor EDXEDX referralreferral CAUSESCAUSES OFOF RADICULOPATHYRADICULOPATHY HNPHNP RadiculiitisRadiculiitis SpinalSpinal StenosisStenosis SpondylolisthesisSpondylolisthesis InfectionInfection TumorTumor FacetFacet SynovialSynovial CystCyst Diseases:Diseases: Diabetes,Diabetes, AIDPAIDP MUSCULOSKELETALMUSCULOSKELETAL DISORDERSDISORDERS :: UPPERUPPER LIMBLIMB ShoulderShoulder BursitisBursitis LateralLateral EpicondylitisEpicondylitis DequervainsDequervains TriggerTrigger fingerfinger FibrositisFibrositis FibromyalgiaFibromyalgia // regionalregional painpain syndromesyndrome NEUROLOGICALNEUROLOGICAL CONDITIONSCONDITIONS MIMICKINGMIMICKING CERVICALCERVICAL RADICULOPATHYRADICULOPATHY Entrapment/CompressionEntrapment/Compression neuropathiesneuropathies –– Median,Median, Radial,Radial, andand UlnarUlnar BrachialBrachial NeuritisNeuritis MultifocalMultifocal MotorMotor NeuropathyNeuropathy NeedNeed ExtensiveExtensive EDXEDX studystudy toto R/OR/O otherother conditionsconditions MUSCULOSKELETALMUSCULOSKELETAL DISORDERSDISORDERS :: LOWERLOWER LIMBLIMB HipHip arthritisarthritis TrochantericTrochanteric BursitisBursitis IlliotibialIlliotibial BandBand
    [Show full text]
  • Provider Type 72 Nurse Anesthetist Reimbursement Rates
    Provider Type 72 Nurse Anesthetist Reimbursement Rates Updated: May 1, 2015 The information contained in the schedule is made available to provide information and is not a guarantee by the State or the Department or its employees as to the present accuracy of the information contained herein. For example, coverage as well as an actual rate may have been revised or updated and may no longer be the same as posted on the website. Note: Procedure codes with a rate of $0.00 are reimbursed at 62% of Usual and Customary charges unless noted otherwise in Nevada Medicaid policy. CPT codes, descriptions and other data only are copyright © 2008 American Medical Association. All rights reserved. Applicable FARS/DFARS apply. CPT is a registered trademark ® of the American Medical Association. Modifier List Anesthesiology Unit Values Proc Code Description Mod Rate 01953 ANESTH BURN EACH 9 PERCENT 21.12 01996 HOSP MANAGE CONT DRUG ADMIN 63.36 10021 FNA W/O IMAGE TC 12.96 10021 FNA W/O IMAGE 26 48.11 10021 FNA W/O IMAGE 61.32 10022 FNA W/IMAGE TC 17.20 10022 FNA W/IMAGE 26 45.87 10022 FNA W/IMAGE 63.07 10040 ACNE SURGERY 45.12 10060 DRAINAGE OF SKIN ABSCESS 49.86 10061 DRAINAGE OF SKIN ABSCESS 103.70 10080 DRAINAGE OF PILONIDAL CYST 51.35 10081 DRAINAGE OF PILONIDAL CYST 108.69 10120 REMOVE FOREIGN BODY 42.87 10121 REMOVE FOREIGN BODY 122.40 10140 DRAINAGE OF HEMATOMA/FLUID 66.06 10160 PUNCTURE DRAINAGE OF LESION 44.62 10180 COMPLEX DRAINAGE WOUND 98.47 11000 DEBRIDE INFECTED SKIN 22.68 11001 DEBRIDE INFECTED SKIN ADD-ON 10.96 11010 DEBRIDE SKIN AT FX
    [Show full text]